I. Diop Mar
- Epidemiology
- Hepatology top 5%
- Microbiology top 5%
- Infectious Diseases
- Immunology
- Topics
- Hepatitis B Virus Studies (6 papers)Bacterial Infections and Vaccines (6 papers)Hepatitis C virus research (4 papers)
- Cited by
- HepatologyMicrobiologyEpidemiology
In The Last Decade
I. Diop Mar
26 papers receiving 278 citations
Peers
Comparison fields: 5 of 56
- Epidemiology 240
- Hepatology 118
- Microbiology 80
- Infectious Diseases 55
- Immunology 26
Countries citing papers authored by I. Diop Mar
This map shows the geographic impact of I. Diop Mar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Diop Mar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Diop Mar more than expected).
Fields of papers citing papers by I. Diop Mar
This network shows the impact of papers produced by I. Diop Mar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Diop Mar. The network helps show where I. Diop Mar may publish in the future.
Co-authorship network of co-authors of I. Diop Mar
This figure shows the co-authorship network connecting the top 25 collaborators of I. Diop Mar. A scholar is included among the top collaborators of I. Diop Mar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Diop Mar. I. Diop Mar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Hepatitis B virus infection in lepromatous and tuberculoid patients from Senegal. | 6 |
| 2 | 25 | |
| 3 | 76 | |
| 4 | 2 | |
| 5 | Comparative double-blind study of the tolerance and efficacy of ivermectin and diethylcarbamazine citrate in the treatment of human onchocerciasis | 3 |
| 6 | [Anti-BCG titers of healthy and tuberculous Africans. Use of the indirect immunoperoxidase test]. | 1 |
| 7 | 5 | |
| 8 | [An epidemiological study of purulent meningitis cases admitted to hospital in Dakar, 1970-1979]. | 77 |
| 9 | 3 | |
| 10 | [The prognosis and treatment of pneumococcal meningitis in Africa. 402 cases (author's transl)]. | 3 |
| 11 | Aspects of the treatment of purulent meningitis peculiar to Africa. | 1 |
| 12 | 10 | |
| 13 | 7 | |
| 14 | Incidence des shigelloses en milieu hospitalier dakarois sur une période de quatre ans (1973-1976). | 1 |
| 15 | [Incidence of shigelloses in Dakar hospitals in a 4-year period (1973-1976)]. | 1 |
| 16 | 1 | |
| 17 | [The rapid detection and specific identification of bacterial antigens by electro-immunodiffusion in 80 cases of purulent meningitis (author's transl)]. | 1 |
| 18 | [Comatose forms of purulent meningitis]. | 0 |
| 19 | [Influence of protein and calorie malnutrition on infections. Results of a Senegalese hospital study]. | 1 |
| 20 | The problem of post-yellow fever vaccination encephalitis. | 1 |
About I. Diop Mar
I. Diop Mar is a scholar working on Endocrinology, Microbiology and Hepatology, having authored 28 papers that have together received 311 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), Bacterial Infections and Vaccines (6 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Hepatology (118 citations), Microbiology (80 citations) and Epidemiology (240 citations). I. Diop Mar has collaborated with scholars based in France and Senegal. Frequent co-authors include F. Denis, M. Cadoz, J.P. Chiron, Pierre Coursaget, B Yvonnet, J. Chotard, R N'Doye, A Goudeau, Marie-Noëlle Mévélec and Françis Barin. Their work appears in journals such as The Lancet, Infection and Immunity and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.